Biogen will purchase a drug firm for $5.6 billion to broaden work in kidney ailments
Biogen, already developing a drug that can be used to treat several kidney disorders, is paying a large premium for Apellis Pharmaceuticals
Trending
- FBI: Michigan Synagogue Assault Was Hezbollah-Impressed Terror Plot
- How sea mines threaten international commerce, and the way navies detect them
- How dominant October set Vladimir Guerrero Jr. up for 2026 success
- Controversial Transfer Triggers Spiritual Outrage as Battle in Iran Continues | Day by day Pulse
- Epstein Uncovered: Sufferer’s Tales Reveal Satanic, Unfathomable Crimes
- Netherlands Euthanizes Teenager With Autism
- NEW: Florida Airport To Be Formally Renamed After President Donald Trump
- Crimson Desert’s newest patches make it much more of a GOTY contender
- Dem Iowa Home candidate claimed public shows of Christianity felt ‘very threatening’
- Restricted missions, large perils: What a US floor struggle in Iran might change into